KC

Knoll Capital Management

Description

Knoll Capital Management is a venture capital firm thats invests in firms focused in information technology sector.

Investor Profile

Knoll Capital Management has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Post Ipo Equity, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series Unknown (50%)
  • Post Ipo Equity (25%)
  • Series B (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Precision Medicine
  • Health Diagnostics
  • Neuroscience
  • Genetics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Knoll Capital Management frequently co-invest with?

Connecticut Innovations
North America, Connecticut, United States, Rocky Hill
Co-Investments: 2
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Aperture Venture Partners
North America, New York, United States, New York
Co-Investments: 2
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 2
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1
Venrock
North America, California, United States, Palo Alto
Co-Investments: 2
Aisling Capital
North America, New York, United States, New York
Co-Investments: 2

Which angels does Knoll Capital Management often collaborate with?

CI
North America, New York, United States, New York
Shared Deals: 1
Shared Deals: 2
GB
Europe, England, United Kingdom, London
Shared Deals: 2

What are some of recent deals done by Knoll Capital Management?

electroCore

Basking Ridge, New Jersey, United States

ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.

Health CareMedical DeviceTherapeutics
Series BNov 29, 2017
Amount Raised: $34,000,000
Exicure

Chicago, Illinois, United States

Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets.

BiotechnologyGeneticsLife ScienceTherapeutics
Series UnknownNov 6, 2017
Amount Raised: $11,200,000
Bristol-Myers Squibb

New York, New York, United States

Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.

BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Post Ipo EquityFeb 21, 2017
Amount Raised: $80,000,000
Biohaven Pharmaceutical

New Haven, Connecticut, United States

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

BiotechnologyHealth CareHealth DiagnosticsNeurosciencePharmaceutical
Series UnknownNov 1, 2016
Amount Raised: $80,000,000

Find More Investors Like Knoll Capital Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Knoll Capital Management | Pipeseed